To which of the following therapeutic drug classes does hydromorphone HCl belong?

A. Hydromorphone HCl does not act directly on the motor end plate or the spinal cord to reduce skeletal muscle tone. It is not classified as a spasmolytic or neuromuscular blocker. Its primary therapeutic indication is not the relief of muscle spasms. B. This agent does not inhibit cyclooxygenase 1 or 2 enzymes. It lacks the peripheral anti-inflammatory, antipyretic, and antiplatelet properties characteristic of drugs like ibuprofen or aspirin. It does not reduce prostaglandin synthesis at the site of tissue injury. C. While it may cause sedation as a side effect, it is not indicated for the clinical management of generalized anxiety disorder. It does not modulate gamma-aminobutyric acid receptors in the same manner as benzodiazepines. Its use is strictly regulated. D. Hydromorphone HCl is a potent mu-opioid receptor agonist within the central nervous system. It alters the perception of and emotional response to pain by inhibiting ascending pain pathways. This mechanism of action defines its classification as an opioid analgesic.